Home › Cases › Bradyarrhythmia — Drug-Induced
Bradyarrhythmia
Bradyarrhythmia — Drug-Induced
6 questions
Question 1 · Beta-blocker bradycardia
Correct answer: Stop both drugs. IV atropine 500mcg to 3mg total. If refractory: glucagon 5-10mg IV (β-blocker antidote), calcium chloride/gluconate (CCB antidote), transcutaneous pacing
Why
β-blocker + CCB combination causes additive AV conduction suppression → severe bradycardia.
- Stop offending drugs
- Atropine IV (1st line)
- Glucagon 5-10mg IV bolus → infusion (activates cAMP independent of β-receptor)
- Calcium chloride 10ml of 10% (CCB antidote)
- Pacing if pharmacology fails
- IV lipid emulsion (Intralipid) for severe toxicity
Key point
β-blocker + CCB overdose: atropine → glucagon → calcium → pacing. Stop both drugs.
Question 2 · Digoxin toxicity
Correct answer: Digoxin toxicity: stop digoxin. Avoid calcium (worsens toxicity). Give digoxin-specific antibody Fab fragments (DigiFab) for life-threatening toxicity. Correct K+/Mg2+
Why
Digoxin toxicity: STOP digoxin. Check K+/Mg2+ (hypokalaemia/hypomagnesaemia increase toxicity). Do NOT give calcium (worsens toxicity — 'stone heart'). DigiFab for life-threatening toxicity (VT, VF, symptomatic bradycardia, K+ >5.5 in acute). Dose based on ingested dose or digoxin level.
Key point
Digoxin toxicity: stop drug, correct K+/Mg2+, NO calcium, DigiFab for life-threatening. Yellow halos = classic feature.
Question 3 · Sinus node dysfunction
Correct answer: Sick sinus syndrome (SSS). AAIR pacemaker (atrial pacing, inhibited by intrinsic atrial activity) if AV node intact. Otherwise DDDR (rate response)
Why
Sick sinus syndrome (SSS): sinus node dysfunction — sinus bradycardia, pauses, chronotropic incompetence. If AV node intact: AAIR pacemaker preferred (atrial pacing, rate adaptive) — preserves AV synchrony, avoids RV pacing. DDDR if AV node disease also present. Minimising RV pacing reduces pacing-induced cardiomyopathy risk.
Key point
SSS with intact AV node: AAIR pacemaker preferred (reduces unnecessary RV pacing). DDDR if AV conduction impaired.
Question 4 · Sotalol-induced bradycardia
Correct answer: Class IA (quinidine, procainamide) and Class III agents (amiodarone, sotalol, dronedarone) — QT prolongation. Sotalol also β-blocks → bradycardia + QT
Why
Anti-arrhythmic QT/bradycardia risk: Class Ia (quinidine — lupus + QT), Ib (lignocaine — minimal), Ic (flecainide — proarrhythmic in structural heart disease), III (amiodarone — most side effects; sotalol — β-block + QT). Sotalol: β-blockade slows rate + prolongs QT → torsades de pointes risk with hypokalaemia/slow rate.
Key point
Sotalol: β-blocks (bradycardia) + prolongs QT (torsades risk). Amiodarone: most side effects. Avoid hypokalaemia with QT-prolonging drugs.
Question 5 · Hypothyroidism bradycardia
Correct answer: Levothyroxine replacement. Start low dose (25mcg) especially if elderly or cardiac disease — too-rapid correction risks atrial fibrillation and cardiac ischaemia
Why
Hypothyroid bradycardia: sinus bradycardia + low voltage + prolonged QT ± pericardial effusion. Treatment: levothyroxine replacement — start LOW in elderly/cardiac (25mcg) to avoid AF, angina, MI. Increase every 6-8 weeks. Heart rate normalises with treatment. Pacemaker only if persistently symptomatic after treatment.
Key point
Hypothyroid bradycardia: levothyroxine (start low 25mcg in elderly). ECG: sinus brady + low voltage + prolonged QT. No pacing unless persistent.
Question 6 · Carotid sinus hypersensitivity
Correct answer: Carotid sinus hypersensitivity (CSH) — exaggerated vagal response to carotid pressure. Cardioinhibitory type (asystole): dual-chamber pacemaker recommended
Why
Carotid sinus hypersensitivity: exaggerated vagal response to carotid sinus pressure (>3 seconds asystole = cardioinhibitory or vasodepressor = BP drop). Provoked by: neck movements, shaving, tight collars. Diagnosis: CSM during 12-lead monitoring (±tilt table). Treatment: cardioinhibitory → dual-chamber PPM (DDD). SAFE PACE trial: PPM reduced syncope. Vasodepressor: lifestyle modification.
Key point
Carotid sinus hypersensitivity: asystole >3s on CSM. Cardioinhibitory: dual-chamber PPM. Vasodepressor: lifestyle. SAFE PACE trial.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.